InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,664.42
(
0.59%
)
US TECH 100
19,821.20
(
-0.12%
)
Dow Jones
40,945.18
(
1.82%
)
Brent Oil
83.24
(
-1.31%
)
Bitcoin
65,156.43
(
0.47%
)
Post# of 252610
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

lgonber

Send PM Follow Ignore
Followers 12
Posts 648
Boards Moderated 0
Alias Born 12/20/2014

lgonber

Re: DewDiligence post# 196270

Friday, 10/23/2015 7:34:51 AM

Friday, October 23, 2015 7:34:51 AM

Post# of 252610
Good post.COngrats for you purchase at $20. As an investor in GILD and ACHN, yesterday´s news favored my portfolio. I am considering a purchase in ENTA in case it goes back to the levels you bought. My only concern is if doctors are reluctant to prescribe V-pack to all cirrhotic patients (just in case) which is about 25% of patients with hepatitis C. DO you think this could happen? and if so, would that impact in ENTA royalties significantly?
thank you
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up